Neurodegenerative disorders are characterized by complex neurobiological changes that are reflected in biomarker alterations detectable in blood, cerebrospinal fluid (CSF) and with brain imaging. As ...

How AI Is Transforming Trial Design Artificial intelligence has become an integral part of the vision for clinical research ...

New drug development is a race against the clock as soon as the first patents are filed, and understanding the potential timings from first-in-human studies to regulatory approval is crucial for ...

Formulation complexity, especially in small molecule drugs, has been getting more attention as capabilities continue to ...

This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced new capabilities ...

Developed in collaboration with Korea's top clinical and hospital network, the integrated platform combines globally ...

Outsourcing of non-core services and resources is common practice in today’s world as companies look to reduce overhead and costs and streamline their businesses. Pharmaceutical companies outsource ...

HHS Secretary Robert F. Kennedy Jr. wants to speed up clinical trials in the United States.“A recent study found that China ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

VANCOUVER, BC / ACCESS Newswire / June 23, 2026 / Onco-Innovations Limited (NEO:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into a ...